IL-1β not only leads to the inhibitory effect of cancer cells on CD8+ T cells directly, but also recruits other components of immunosuppressive cells, including M2 phenotype macrophages, into the microenvironment, generating a vicious cycle leading to tumor immune escape. Here, IL1B is linked to cancer.